课题基金 / 基金详情

Molecular mechanisms of multidrug binding by the bacterial ABC transporter Sav1866

Molecular mechanisms of multidrug binding by the bacterial ABC transporter Sav1866
细菌ABC转运蛋白Sav1866多药结合的分子机制
批准号:
BB/F008333/1
负责人:
Hendrik Willem Van Veen
金额:
$38.41万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2008
资助国家:
英国
项目状态:
已结题
起止时间:
2008 至 --

项目摘要

项目成果

Hendrik Willem Van Veen的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Multidrug transporters are very small molecular machines that are present at the surface of human cells and microorganisms. These ingenious machines provide the cell with a defense mechanism against toxic compounds which are harmful to them. The activity of multidrug transporters interferes with the drug-based control, also termed 'chemotherapy', of human tumours and infectious pathogenic microorganisms, in which drugs are designed to kill the cell. Multidrug transporters bind structurally unrelated drugs and toxins at the inside of the cell, and then move these compounds to the outside of the cell, away from the targets with which the drugs are supposed to interact. Hence, multidrug transporters act as drug pumps that are able to lower the drug concentration inside the cell to levels at which these drugs are inactive and useless. As drugs now have lost their therapeutic effects, the cell has become 'multidrug resistant'. This project focuses on the bacterial multidrug transporter Sav1866, which is very similar to one of the major multidrug pumps in human. Sav1866 is made by the pathogenic bacterium Staphylococcus aureus, but we use the non-pathogenic, food-grade bacterium Lactococcus lactis to study the properties of the pump. Sav1866 is particularly interesting as researchers have very recently been able to determine its three-dimensional structure. In this project, we study how Sav1866 recognizes and binds drugs. This knowledge might allow us to rationally design new drugs that can poison or circumvent the activity of these transport proteins in microorganisms and human cells to improve chemotherapy of cancers and infectious diseases.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1038/nmeth.1347
发表时间: 2009-08
期刊: NATURE METHODS
影响因子: 48
作者: [Barrera, Nelson P., Isaacson, Shoshanna C., Zhou, Min, Bavro, Vassiliy N., Welch, Alex, Schaedler, Theresia A., Seeger, Markus A., Miguel, Ricardo Nunez, Korkhov, Vladimir M., van Veen, Hendrik W., Venter, Henrietta, Walmsley, Adrian R., Tate, Christopher G., Robinson, Carol V.]
通讯作者: Robinson, Carol V.
DOI: --
发表时间: 2009
期刊: Journal of Applied Statistics
影响因子: 1.5
作者: [A. Ponte-Sucre]
通讯作者: A. Ponte-Sucre
MacB ABC transporter is a dimer whose ATPase activity and macrolide-binding capacity are regulated by the membrane fusion protein MacA.
MacB ABC 转运蛋白是一种二聚体,其 ATP 酶活性和大环内酯结合能力受膜融合蛋白 MacA 调节。
DOI: 10.17863/cam.58238
发表时间: 2009
期刊:
影响因子: --
作者: [Lin H]
通讯作者: Lin H
DOI: 10.1016/j.tibs.2009.07.009
发表时间: 2010-01
期刊: Trends in biochemical sciences
影响因子: 13.8
作者: [Gutmann DA, Ward A, Urbatsch IL, Chang G, van Veen HW]
通讯作者: van Veen HW
Mechanisms of substrate transport by the major facilitator superfamily multidrug transporter LmrP
  • 批准号:
    BB/R00224X/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $44.68万
  • 财政年份:
    2017
  • 负责人:
    Hendrik Willem Van Veen
  • 依托单位:
Transport mechanism of a multidrug transporter from Vibrio cholerae
  • 批准号:
    BB/K017713/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $36.39万
  • 财政年份:
    2014
  • 负责人:
    Hendrik Willem Van Veen
  • 依托单位:
Ion transport by the human Breast Cancer Resistance Protein (ABCG2)
  • 批准号:
    BB/I002383/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $42.23万
  • 财政年份:
    2011
  • 负责人:
    Hendrik Willem Van Veen
  • 依托单位:
国内基金
海外基金
Exploring the Intrinsic Mechanisms of CEO Turnover and Market
  • 批准号:
    --
  • 项目类别:
    外国学者研究基金
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    HAOFEI Z
  • 依托单位:
Exploring the Intrinsic Mechanisms of CEO Turnover and Market Reaction: An Explanation Based on Information Asymmetry
  • 批准号:
    W2433169
  • 项目类别:
    外国学者研究基金项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    HAOFEI ZHANG
  • 依托单位:
Erk1/2/CREB/BDNF通路在CSF1R相关性白质脑病致病机制中的作用研究
  • 批准号:
    82371255
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    曹立
  • 依托单位:
Foxc2介导Syap1/Akt信号通路调控破骨/成骨细胞分化促进颞下颌关节骨关节炎的机制研究
  • 批准号:
    82370979
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    张善勇
  • 依托单位: